Ersodetug

埃索德塔单抗

Report date: 2026/05/02 20:00:18

Base Information

Drug NameErsodetug
Drug Alias NameHuman allosteric modulating monoclonal antibody (XOMA)XPA.15.247XOMA-358XOMA-247RZ358 +[6] 
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionInsulin receptor inhibitors
TargetsInsulin receptor
Therapy Area/IndicationsHypoglycemiaHyperinsulinismCongenital Hyperinsulinism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBulgariaCanadaUnited States +[16] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesXoma Corp
China Registration ClassN/A

Develop Information

Active CompaniesRezolute IncRezolute
Inactive CompaniesXoma (Us) Llc
Active IndicationsHyperinsulinismCongenital Hyperinsulinism
Inactive IndicationsHypoglycemia

Other Information

ATC CodeN/A
Related LinksDrugBank